BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BioStem Technologies, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.54−0.55 (-26.32%)
Close on Oct 19, 2026
- Market cap
- $26.68M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns BioStem Technologies's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Vurst Andrew Smith-Van | Chief Operating Officer, Director, 10% owner | 1,539,809 | 8.63% | Sep 17, 2026 |
| Jason Matuszewski | Chief Executive Officer, Director, 10% owner | 1,303,552 | 7.30% | Sep 17, 2026 |
| Brandon Poe | Chief Financial Officer | 58,062 | 0.33% | Sep 17, 2026 |
| Michael A. Fortunato | Chief Accounting Officer | 68,664 | 0.38% | Sep 17, 2026 |
| Barry Hassett | Chief Commercial Officer | 5,003 | 0.03% | Sep 11, 2026 |
| Katherine Gorrell | CLCO | – | – | Aug 14, 2026 |
| Kenneth Howard Warrington Jr | Director | 33,928 | 0.19% | Sep 17, 2026 |
| Mark A. Glickman | Director | 7,671 | 0.04% | Aug 28, 2026 |
| Hannaway Rayna Lesser | Director | 7,671 | 0.04% | Aug 28, 2026 |
| Jodi Ungrodt | Director | 11,295 | 0.06% | Aug 28, 2026 |
| Steven D. Sonenreich | Director | 7,671 | 0.04% | Aug 28, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Vurst Andrew Smith-Van Chief Operating Officer, Director, 10% owner | Sep 17, 2026 | Option exercise | +9,574 | – | – | 1,539,809 |
| Jason Matuszewski Chief Executive Officer, Director, 10% owner | Sep 17, 2026 | Option exercise | +16,650 | – | – | 1,303,552 |
| Kenneth Howard Warrington Jr Director | Sep 15, 2026 | Option exercise | +1,694 | – | – | 33,928 |
| Brandon Poe Chief Financial Officer | Sep 15, 2026 | Option exercise | +1,694 | – | – | 58,062 |
| Vurst Andrew Smith-Van Chief Operating Officer, Director, 10% owner | Sep 15, 2026 | Option exercise | +7,622 | – | – | 1,530,235 |
| Michael A. Fortunato Chief Accounting Officer | Sep 15, 2026 | Option exercise | +4,234 | – | – | 68,664 |
| Jason Matuszewski Chief Executive Officer, Director, 10% owner | Sep 15, 2026 | Option exercise | +8,469 | – | – | 1,286,902 |
| Barry Hassett Chief Commercial Officer | Sep 9, 2026 | Option exercise | +500 | – | – | 5,003 |
| Mark A. Glickman Director | Aug 27, 2026 | Option exercise | +7,671 | – | – | 7,671 |
| Hannaway Rayna Lesser Director | Aug 27, 2026 | Option exercise | +7,671 | – | – | 7,671 |
| Jodi Ungrodt Director | Aug 27, 2026 | Option exercise | +5,647 | – | – | 11,295 |
| Steven D. Sonenreich Director | Aug 27, 2026 | Option exercise | +7,671 | – | – | 7,671 |
| Kenneth Howard Warrington Jr Director | Aug 27, 2026 | Option exercise | +5,094 | – | – | 32,234 |
| Brandon Poe Chief Financial Officer | Aug 11, 2026 | Option exercise | +10,634 | – | – | 56,368 |
| Michael A. Fortunato Chief Accounting Officer | Aug 9, 2026 | Option exercise | +970 | – | – | 64,430 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.